ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 253 filers reported holding ARGENX SE in Q3 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,602,811 | +193.0% | 33,771 | +132.3% | 0.01% | +180.0% |
| Q2 2023 | $5,666,275 | +24.7% | 14,539 | +19.2% | 0.01% | +25.0% |
| Q1 2023 | $4,543,981 | +162.0% | 12,196 | +166.4% | 0.00% | +100.0% |
| Q4 2022 | $1,734,284 | -11.7% | 4,578 | -17.7% | 0.00% | 0.0% |
| Q3 2022 | $1,963,000 | +17.7% | 5,560 | +26.3% | 0.00% | 0.0% |
| Q2 2022 | $1,668,000 | +16.6% | 4,403 | -2.9% | 0.00% | +100.0% |
| Q1 2022 | $1,430,000 | +7.6% | 4,534 | +19.4% | 0.00% | 0.0% |
| Q4 2021 | $1,329,000 | – | 3,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
| Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
| Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
| Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
| Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
| DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
| Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
| Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
| Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
| Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |